{"article_title": "CMS\u2019s Radical Experiment On Pricing Of Part B Drugs", "article_keywords": ["b", "vitriol", "mcmanus", "drugs", "radical", "cmss", "administration", "sales", "experiment", "pricing", "unveiled", "scrap", "reimburses", "asp", "price"], "article_url": "http://www.lifescienceleader.com/doc/cms-s-radical-experiment-on-pricing-of-part-b-drugs-0001", "article_text": "CMS's Radical Experiment On Pricing Of Part B Drugs\n\nBy John McManus, president and founder, The McManus Group\n\nCapitalizing on the growing vitriol directed at the pharmaceutical industry, the Obama administration unveiled a farreaching and aggressive \u201cdemonstration project\u201d that would fundamentally change how physician-administered drugs are reimbursed by Medicare.\n\nThe administration proposes to scrap the current market-based \u201caverage sales price\u201d (ASP) payment formula, which reimburses physicians and hospitals 106 percent of the ASP of a Part B drug (accounting for all discounts, rebates, and other price concessions).", "article_metadata": {"twitter": {"image": {"src": "http://vertassets.blob.core.windows.net/image/023b0cda/023b0cda-5230-4bd2-8c8e-8c8b4c81dbf1/03_0416_capitolperspectives.jpg"}, "title": "CMS's Radical Experiment On Pricing Of Part B Drugs", "description": "<p><span calibri=\"\" style=\"font-size:11.0pt;font-family:\">If CMS wins this battle over physician-administered Part B drugs, it will be emboldened to pursue even more radical &ldquo;demonstrations&rdquo; in Medicare Part D.</span></p>", "card": "summary_large_image", "site": "RFWrightLSL"}, "description": "If CMS wins this battle over physician-administered Part B drugs, it will be emboldened to pursue even more radical &ldquo;demonstrations&rdquo; in...", "viewport": "width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no", "Title": "CMS\u2019s Radical Experiment On Pricing Of Part B Drugs"}, "article_summary": "CMS's Radical Experiment On Pricing Of Part B DrugsBy John McManus, president and founder, The McManus GroupCapitalizing on the growing vitriol directed at the pharmaceutical industry, the Obama administration unveiled a farreaching and aggressive \u201cdemonstration project\u201d that would fundamentally change how physician-administered drugs are reimbursed by Medicare.\nThe administration proposes to scrap the current market-based \u201caverage sales price\u201d (ASP) payment formula, which reimburses physicians and hospitals 106 percent of the ASP of a Part B drug (accounting for all discounts, rebates, and other price concessions)."}